Lagging Pfizer Revenue Reinvigorates M&A Speculation
Pfizer Inc. reported a revenue drop on Tuesday thanks in part to once-hot products that continue to lag, ramping up pressure for the company to renew its acquisition push for AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article